A phase II study of oral Panobinostat in adult patients with relapsed/refractory classical Hodgkin's lymphoma after failure of high-dose chemotherapy with autologous stem cell transfusion and a Gemicitabine- or Vinorelbine- or Vinblastine-containing reg
|Effective start/end date
|6/15/08 → 1/30/11
- NOVARTIS PHARMACEUTICALS CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.